Karyopharm Therapeutics | KPTI - Ebit





Ebit Veränderung Datum
AbbVie USD 6.88B 156M 2026-09
Abbott USD 1.36B 775M 2026-09
Amgen USD 4.68B 65M 2026-09
AstraZeneca USD 4.66B 1.5B 2026-09
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Bristol-Myers Squibb USD 255M 44M 2026-09
Eli Lilly USD 13.09B 635M 2026-09
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
GlaxoSmithKline GBP 2.86B 251M 2026-09
Incyte USD -707.47M 1.41B 2026-09
J&J USD 6.47B 1B 2026-09
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
MacroGenics USD -65.25M 33.36M 2026-06
Merck USD 7.33B 6.49B 2026-09
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Novartis USD 5.14B 411M 2026-09
Novartis USD 1.78B 2.4B 2026-09
Pfizer USD 4.85B 5.03B 2026-09
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Takeda JPY 205.32B 3.9B 2026-09
Tectonic Therapeutic USD -24.22M 3.08M 2026-06
TG Therapeutics USD 21.67M 13.12M 2026-06
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
Xencor USD -36.6M 41.26M 2026-06